PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cell-destroyer that fights and promotes TB reveals what's behind its split identity

Findings have potential to revert hypersusceptibility to TB to hyperresistance

2013-04-11
(Press-News.org) Tumor necrosis factor – normally an infection-fighting substance produced by the body– can actually heighten susceptibility to tuberculosis if its levels are too high.

University of Washington TB researchers unravel this conundrum in a report this week in Cell.

Their study shows how excess production of this disease-cell destroyer at first acts as a TB germ killer. But later the opposite occurs: too much tumor necrosis factor encourages TB pathogens to multiply in the body.

In addition to figuring out some reasons behind this back-pedaling, the scientists learned that certain combinations of drugs already available for other conditions can curtail the shift from anti-TB to pro-TB.

The drug combination revealed in this study, the authors noted, "has the potential to revert some cases of hypersusceptibility to hyperresistance."

The scientists were Francisco Jose Roca Soler, of the UW Department of Microbiology, and Lalita Ramakrishnan, UW professor of microbiology, medicine and immunology. A recipient of the National Institutes of Health Director's Pioneer Award, Ramakrishnan is recognized for her work on how the TB pathogen and its hosts' cells interact to cause disease.

These studies are conducted in zebrafish, an animal model for tuberculosis. The fish's embryos and small fry are transparent. Researchers can see through their skin to observe their organs, tissues and cells and the internal appearance of some infections, for example, the bacterial cording of TB.

Roca and Ramakrishnan explained that TB had traditionally been thought of as a disease of failed immunity. However, more recent studies from their lab and other labs, both in zebrafish and in humans, have suggested that it also can result from too strong of a defensive inflammatory response.

"While tumor necrosis factor is a critical host defense against tuberculosis," Roca and Ramakrishnan noted, "an excess of this factor is also implicated in the development of the disease in zebrafish and in humans."

Variations in a specific location of the zebrafish genome can cause either too much or too little tumor necrosis factor to be produced, depending on the type of variation. In either case, deficiency or overabundance, zebrafish become prone to tuberculosis.

In both cases the scavenger cells, or macrophages, that are trying to clear away the TB pathogens by ingesting them, die and burst open. They are like torn vacuum cleaner bags spilling their dirty contents.

When the TB bacteria escape the confines of the scavenger cells, "they grow exuberantly in the extracellular environment," Roca and Ramakrishnan said.

Researchers needed to work out the differences between TB susceptibility caused by too high or too low tumor necrosis factors because the distinction is vital to treatment decisions. Only patients whose genetics made them launch a pro-inflammatory response, benefited from steroid treatment, previous studies have shown. Steroids can increase the chance of death among TB patients with a weak inflammatory response.

In the present study, Roca and Ramakrishnan elucidated the molecular pathways by which too much tumor necrosis factor at first rapidly promotes macrophages to go after TB bacteria, and then turns around and forces the hard-working macrophages to die and expel their captives.

They found that both the microbiocidal activity, and the death of the macrophages, resulted from upping the production of reactive oxygen species by the mitochondria inside the macrophages. Mitochondria are the energy-generating power plants of living cells.

Tumor necrosis factor inside of infected macrophages induces reactive oxygen species from the mitochondria. These are the chemicals responsible for cell damage from oxidative stress.

Early on, reactive oxygen species can be beneficial. Initially their presence encourages the macrophages to destroy pathogens. As they accumulate, however, they promote self-harm.

Suddenly the macrophage is programmed to self-destruct. The reactive oxygen species carry out the death sentence by modulating a pathway for a substance called cyclophilin D, which sets the stage for the demolition of mitochondria.

Reactive oxygen species also play a role in acid sphingomyelinase-mediated ceramide production. This waxy substance occurs in cell membranes. One of its many roles is regulating signals for cell death.

The researchers were able to convert the high tumor necrosis factor state to become resistant to tuberculosis. They did so by genetically blockading both cyclophilin D and acid sphingomyelinase in previously susceptible zebrafish.

Similarly, they discovered that the drug combination of alisporivir, a cyclophilin D-inhibiting drug, and desipramine, an antidepressant that inactivates acid sphingomyelinase, also reverses susceptibility to TB in zebrafish prone to tumor necrosis factor excess.

Essentially, the experiments suggest that preventing cell death in TB infected macrophages can prolong their capacity to attack TB pathogens.

A longer-living army of macrophages, filled with the microbiocidal reactive oxygen species, will destroy the TB pathogens inside them and make the host highly resistant to tuberculosis.

Because excessive amounts of tumor necrosis factor are implicated in several inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, sarcoidosis, and Crohn's, the authors noted, "The findings may be useful for understanding diseases in addition to tuberculosis."



INFORMATION:



Grants from the National Institutes of Health and the Northwest Research Center of Excellence for Biodefense and Emerging Diseases, and a postdoctoral fellowship from the educational ministry of Spain, funded this research project.

The Cell paper is titled, "Tumor necrosis factor dually mediates resistance and susceptibility to mycobacteria through induction of mitochondrial reactive oxygen species."



ELSE PRESS RELEASES FROM THIS DATE:

How some leaves got fat: It's the veins

2013-04-11
A "garden variety" leaf is a broad, flat structure, but if the garden happens to be somewhere arid, it probably includes succulent plants with plump leaves full of precious water. Fat leaves did not emerge in the plant world easily. A new Brown University study published in Current Biology reports that to sustain efficient photosynthesis, they required the evolution of a fundamental remodeling of leaf vein structure: the addition of a third dimension. Leaves, after all, are food factories complete with plumbing to transport water and sugar. The farther those veins are ...

The mathematical method for simulating the evolution of the solar system has been improved

2013-04-11
In order to improve a simulation designed to study the evolution of the solar system through time, numerical mathematical methods have been developed at the Computing Faculty of the University of the Basque Country (UPV/EHU). Specifically, the methods proposed enable the simulation calculations to be done faster and more accurately. The methodology developed at the UPV/EHU's Computing Faculty is a clear example of interdisciplinarity and collaboration. Indeed, mathematicians, computer scientists, physicists and astronomers have been working together on this task, and ...

Healing by the clock

2013-04-11
Circadian rhythms keep time for all living things, from regulating when plants open their flowers to foiling people when they try to beat jet lag. Day-night cycles are controlled through ancient biological mechanisms, evolutionarily speaking, so in essence, a human has the same internal clock as a fly does. These circadian clocks govern daily rhythms through genes that synchronize molecular pathways that promote or repress protein production, influencing a multitude of body functions. Even before waking, for example, our clock-driven metabolism turns on enzymes and transporters ...

Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology

2013-04-11
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true. On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery. The drug is the first triumph of the nascent field of synthetic biology and will be, Keasling hopes, a lifesaver for the hundreds of millions of people in developing ...

Magical survey shows voters are less partisan than indicated by polls

2013-04-11
Traditional opinion polls may severely underestimate the openness for political change among voters, according to research published on 10 April in the open access journal PLOS ONE. Polarisation and partisanship in politics are a constant topic of discussion, and political candidates often believe they must focus their campaign efforts on a small number of swing voters open to ideological change. Based on the wisdom of opinion polls, this might seem like a good idea. But do most voters really hold their political attitudes so firmly that they are unreceptive to persuasion? ...

Diamond as a building material for optical circuits

2013-04-11
This press release is available in German. The application of light for information processing opens up a multitude of possibilities. However, to be able to adequately use photons in circuits and sensors, materials need to have particular optical and mechanical properties. Researchers at the Karlsruhe Institute of Technology (KIT) have now for the first time used polycrystalline diamond to manufacture optical circuits and have published their results online in Nature Communications (DOI: 10.1038/ncomms2710). "Diamond has several properties that allow us to manufacture ...

A new treatment option for alcohol dependence: Reduced consumption rather than abstinence

2013-04-11
Philadelphia, PA, April 11, 2013 – A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry. Traditionally, abstinence has been regarded as the primary treatment goal for alcohol dependence, and current pharmacological treatments for alcoholism are approved only for relapse prevention. However, relapse rates remain high and a goal of abstinence is unacceptable to many patients. To address these concerns and provide opportunities ...

LSUHSC research discovers new drug target for metastatic breast cancer

2013-04-11
New Orleans, LA – Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs. The research is published this week online in the Journal of Biological Chemistry. Working in a mouse model, the LSUHSC research team studied LKB1, an enzyme that functions as a tumor suppressor in the small intestine, and Nischarin, a novel protein that regulates breast cancer cell ...

Information technology amplifies irrational group behavior

2013-04-11
Web tools and social media are our key sources of information when we make decisions as citizens and consumers. But these information technologies can mislead us by magnifying social processes that distort facts and make us act contrary to our own interests – such as buying property at wildly inflated prices because we are led to believe that everybody else is. New research from the University of Copenhagen, which has just been published in the journal Metaphilosophy, combines formal philosophy, social psychology, and decision theory to understand and tackle these phenomena. "Group ...

New findings on the brain's immune cells during Alzheimer's disease progression

2013-04-11
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one hundred years ago. But until today it still remains unclear what role microglia play in Alzheimer's disease. Do they help to break down the plaque deposit? A study by researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité – Universitätsmedizin Berlin has now shed light on these mysterious microglia during the progression of Alzheimer's disease. (PLOS One, ...

LAST 30 PRESS RELEASES:

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

[Press-News.org] Cell-destroyer that fights and promotes TB reveals what's behind its split identity
Findings have potential to revert hypersusceptibility to TB to hyperresistance